Page last updated: 2024-11-05

oxythiamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Oxythiamine: Thiamine antagonist, antimetabolite. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

oxythiamine(1+) : A 1,3-thiazolium cation that is 5-(2-hydroxyethyl)-4-methyl-1,3-thiazole alkylated at the N3 position by a (2-methyl-4-oxo-1,4-dihydropyrimidin-5-yl)methyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8682
CHEMBL ID3305956
CHEBI ID78249
SCHEMBL ID13741267
MeSH IDM0015701

Synonyms (27)

Synonym
oxythiamine
5-(2-hydroxyethyl)-3-((4-hydroxy-2-methyl-5-pyrimidinyl)methyl)-4-methyl-thiazolium
oxythiamin
brn 4153910
thiazolium, 5-(2-hydroxyethyl)-3-((4-hydroxy-2-methyl-5-pyrimidinyl)methyl)-4-methyl-
thiazolium, 3-((1,4-dihydro-2-methyl-4-oxo-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-
5-[[5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium-3-yl]methyl]-2-methyl-1h-pyrimidin-6-one
136-16-3
1mf36syz22 ,
unii-1mf36syz22
thiazolium, 3-((3,4-dihydro-2-methyl-4-oxo-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl-
oxythiamine ion
oxythiamine cation
5-(2-hydroxyethyl)-4-methyl-3-[(2-methyl-4-oxo-1,4-dihydropyrimidin-5-yl)methyl]-1,3-thiazol-3-ium
oxythiamine(1+)
CHEBI:78249 ,
SCHEMBL13741267
CHEMBL3305956
AKOS032954800
Q27147706
CS-0028461
HY-107430
DTXSID40929206
oxythiamine (hydroxythiamin)
5-(2-hydroxyethyl)-4-methyl-3-[(2-methyl-6-oxo-1,6-dihydropyrimidin-5-yl)methyl]-1,3-thiazol-3-ium
5-(2-hydroxyethyl)-4-methyl-3-((2-methyl-6-oxo-1,6-dihydropyrimidin-5-yl)methyl)thiazol-3-ium
AKOS040733951

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In a pharmacodynamic study, nude mice with xenografted HCT-116 tumors were dosed with 1 ('N3'-pyridyl thiamine'; 3-(6-methyl-2-amino-pyridin-3-ylmethyl)-5-(2-hydroxy-ethyl)-4-methyl-thiazol-3-ium chloride hydrochloride), an analog of thiamine, the co-factor of transketolase."( Synthesis, in vitro and in vivo activity of thiamine antagonist transketolase inhibitors.
Ballard, J; Bernat, B; Boyd, SA; Brandhuber, B; Condroski, K; De Meese, J; DeWolf, W; Gonzales, SS; Gunawardana, I; Han, M; Kaplan, T; Le Huerou, Y; Lee, P; Lemieux, C; Lin, J; Pedersen, R; Pheneger, J; Poch, G; Romoff, TT; Smith, D; Sullivan, F; Thomas, AA; Vigers, G; Weiler, S; Wright, SK, 2008
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
antimetaboliteA substance which is structurally similar to a metabolite but which competes with it or replaces it, and so prevents or reduces its normal utilization.
vitamin B1 antagonistAn antagonist which acts by inhibiting the action of vitamin B1
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
1,3-thiazolium cationAn organic cation resulting from protonation or quaternisation at the 3-position of any 1,3-thiazole.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (3)

PathwayProteinsCompounds
Vitamin B1/Thiamine Metabolism819
thiamine formation from pyrithiamine and oxythiamine (yeast)015
thiamine formation from pyrithiamine and oxythiamine (yeast)317
thiamin formation from pyrithiamine and oxythiamine317

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1851376Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 overexpressing GFP-tagged plasmodium falciparum TPK assessed as inhibition of parasite proliferation in presence of 2.97 uM thiamine by SYBR-based fluorescence assay2022RSC medicinal chemistry, Jul-20, Volume: 13, Issue:7
Thiamine analogues as inhibitors of pyruvate dehydrogenase and discovery of a thiamine analogue with non-thiamine related antiplasmodial activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (158)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990100 (63.29)18.7374
1990's15 (9.49)18.2507
2000's14 (8.86)29.6817
2010's24 (15.19)24.3611
2020's5 (3.16)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews7 (3.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other206 (96.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]